NFA
MGNX icon

Nationwide Fund Advisors’s MacroGenics MGNX Stock Holding History

Nationwide Fund Advisors’s Portfolio MGNX Stock Details MGNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-18,766
Closed -$347K – 1246
2017
Q3 		$347K Hold
18,766
– – ﹤0.01% 2372
2017
Q2 		$329K Hold
18,766
– – ﹤0.01% 2397
2017
Q1 		$349K Sell
18,766
-1,433
-7% -$27.6K ﹤0.01% 2347
2016
Q4 		$413K Sell
20,199
-580
-3% -$14.6K ﹤0.01% 2277
2016
Q3 		$621K Hold
20,779
– – ﹤0.01% 2067
2016
Q2 		$561K Buy
20,779
+576
+3% +$13K ﹤0.01% 2088
2016
Q1 		$379K Sell
20,203
-433
-2% -$8.24K ﹤0.01% 2232
2015
Q4 		$639K Buy
20,636
+572
+3% +$17.4K ﹤0.01% 1982
2015
Q3 		$430K Buy
20,064
+1,856
+10% +$58.2K ﹤0.01% 2202
2015
Q2 		$691K Buy
18,208
+3,555
+24% +$117K ﹤0.01% 2063
2015
Q1 		$460K Sell
14,653
-497
-3% -$16.8K ﹤0.01% 2279
2014
Q4 		$531K Sell
15,150
-282
-2% -$7.03K ﹤0.01% 2149
2014
Q3 		$323K Buy
15,432
+171
+1% +$3.54K ﹤0.01% 2473
2014
Q2 		$332K Buy
15,261
+317
+2% +$6.66K ﹤0.01% 2486
2014
Q1 		$416K Buy
14,944
+6,972
+87% +$246K ﹤0.01% 2138
2013
Q4 		$219K Buy
+7,972
New +$209K ﹤0.01% 2645

Other funds holding MGNX

O
OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BB
BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
IVM
InterWest Venture Management San Francisco, California $20.6M AUM 48.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Nationwide Fund Advisors's MGNX Position: Q4 2017 in Review

Nationwide Fund Advisors sold out of MacroGenics (MGNX) in Q4 2017, closing a stake of 18,766 shares — an estimated $347K sold.

Nationwide Fund Advisors first reported a position in MGNX in Q4 2013 and held it in 16 quarters. The position peaked at $691K in Q2 2015. 119 funds tracked by Wall St. Rank hold MGNX as of Q4 2017.

  • Nationwide Fund Advisors reported no remaining MacroGenics position as of Q4 2017 after selling out during the quarter.
  • Nationwide Fund Advisors sold 18,766 MacroGenics shares in Q4 2017, an estimated $347K.
  • Nationwide Fund Advisors first reported a position in MacroGenics in Q4 2013 and held it in 16 quarters.
  • Nationwide Fund Advisors's MacroGenics position peaked at $691K in Q2 2015.
  • 119 funds tracked by Wall St. Rank held MacroGenics as of Q4 2017.

Based on Nationwide Fund Advisors's 13F filing for Q4 2017, filed 1 Feb 2018.